Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_assertion type Assertion NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_head.
- NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_assertion description "[For secondary VTE, a Q360H apolipoprotein A4 gene polymorphism (OR, 0.34; 95% CI, 0.18 to 0.65; P=0.001; FDR, P=0.07) and an I50V interleukin-4 receptor polymorphism (OR, 0.66; 95% CI, 0.52 to 0.84; P=0.0009; FDR, P=0.07) were moderately, but not statistically and significantly, associated with reduced risk after adjustment for multiple comparisons.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_provenance.
- NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_assertion evidence source_evidence_literature NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_provenance.
- NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_assertion SIO_000772 16651467 NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_provenance.
- NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_assertion wasDerivedFrom gad-20150221 NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_provenance.
- NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_assertion wasGeneratedBy ECO_0000203 NP134954.RAubURd7rPLbl33Vzci80vahM23Xbli2XfcUMFVgQzZNA130_provenance.